SRMA | SRMA R | SRMA Th | Syst Inflam | ME | CNS-Mix | IE | Healthy | ||
---|---|---|---|---|---|---|---|---|---|
IL-6 | CSF | 1582 | 637.7 | 0 | 0 | 3 | 0 | 0 | 3 |
(pg/mL) | (163.1-3473) | (17.19-1507) | (0–1.5) | (0–31.25) | (0–175.6) | (0–3) | (0–3) | (0.75-3) | |
Serum | 3 | 17.13 | 0 | 17.13 | 0 | 0 | 1.5 | 3 | |
(pg/mL) | (3–124) | (3–36.24) | (0–0) | (0–77.1) | (0–3) | (0–3) | (0–3) | (0–3) | |
VEGF | CSF | 36.31 | 20.80 | 0 | 0 | 0 | 0 | 0 | 0 |
(pg/mL) | (1–175.2) | (0–69.96) | (0–0) | (0–0) | (0–65.71) | (0–0) | (0–0) | (0–0) | |
Serum | 43.92 | 33.71 | 3.9 | 3.9 | 0 | 0 | 0 | 3.9 | |
(pg/mL) | (3.9-94.5) | (0.98-42.9) | (0–3.9) | (3.9-57.8) | (0–3.9) | (0–3.9) | (0–0) | (1.95-3.9) | |
TGF-β 1 | CSF | 90 | n.a. | n.a. | n.a. | 58 | 0 | n.a. | 0 |
(pg/mL) | (0–429) | (0–214) | (0–95) | (0–0) | |||||
Serum | 13.57 | n.a. | n.a. | n.a. | 22.84 | 19.31 | n.a. | 23.84 | |
(ng/mL) | (9.93-19.27) | (11.86-27.96) | (14.77-23.25) | (18.19-29.16) |